Double-dose double-phase use of second generation hepatitis B virus vaccine in patients after living donor liver transplantation: Not an effective measure in transplant recipients

Hepatology Research

Volumn 39, Issue 1, 2009, Pages 7-13

  Yamashiki, Noriyo ^a   Sugawara, Yasuhiko ^a,b   Tamura, Sumihito ^b   Kaneko, Junichi ^b   Matsui, Yuichi ^b   Togashi, Junichi ^b   Kokudo, Norihiro ^a,b   Omata, Masao ^a   Makuuchi, Masatoshi ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

HBcAb positive donor; HBIG; Hepatitis B vaccine; Lamivudine; Liver transplantation; Prophylaxis

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HEBSBULIN IH; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPTAVAX 2; LAMIVUDINE; RECOMBINANT HEPATITIS B SURFACE ANTIGEN VACCINE; RECOMBINANT HEPATITIS B VACCINE; TACROLIMUS; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHEMOPROPHYLAXIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INJECTION SITE PAIN; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; ORGAN DONOR; PRIORITY JOURNAL; VACCINATION;

EID: 58149177181     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00412.x     Document Type: Article

References (28)

1. Samuel D, Muller R, Alexander G et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842-7.
2. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619-26.
3. Shouval D, Samuel D. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: A concise review. Hepatology 2000; 32: 1189-95.
4. Mutimer D, Dusheiko G, Barrett C et al. Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up. Transplantation 2000; 70: 809-15.
5. Perrillo RP, Wright T, Rakela J et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 2001; 33: 424-32.
6. Lo CM, Cheung ST, Lai CL et al. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg 2001; 233: 276-81.
7. Rosenau J, Tillmann HL, Bahr MJ et al. Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation. Transpl Proc 2001; 33: 3637-8.
8. Gane EJ, Angus PW, Strasser S et al. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007; 132: 931-7.
9. Sanchez-Fueyo A, Rimola A, Grande L et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000; 31: 496-501.
10. Sanchez-Fueyo A, Martinez-Bauer E, Rimola A Hepatitis B vaccination after liver transplantation. Hepatology 2002; 36: 257-8.
11. Bienzle U, Gunther M, Neuhaus R, Neuhaus P. Successful hepatitis B vaccination in patients who underwent transplantation for hepatitis B virus-related cirrhosis: Preliminary results. Liver Transpl 2002; 8: 562-4.
12. Angelico M, Di Paolo D, Trinito MO et al. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology 2002; 35: 176-181.
13. Karasu Z, Ozacar T, Akarca U et al. HBV vaccination in liver transplant recipients: Not an effective strategy in the prophylaxis of HBV recurrence. J Viral Hepat 2005; 12: 212-215.
14. Lo CM, Liu CL, Chan SC, Lau GK, Fan ST. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. J Hepatol 2005; 43: 283-7.
15. Rosenau J, Hooman N, Hadem J et al. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 2007; 13: 367-73.
16. Sugawara Y, Makuuchi M, Kaneko J, Akamatsu N, Imamura H, Kokudo N. Living donor liver transplantation for hepatitis B cirrhosis. Liver Transpl 2003; 9: 1181-4.
17. Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kawarasaki H. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transpl 2002; 16: 102-6.
18. Takemura N, Sugawara Y, Tamura S, Makuuchi M. Liver transplantation using hepatitis B core antibody-positive grafts: Review and university of Tokyo experience. Dig Dis Sci 2007; 52: 2472-7.
19. Albeniz Arbizu E, Barcena Marugan R, Oton Nieto E et al. Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results. Transpl Proc 2003; 35: 1848-9.
20. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984; 311: 496-501.
21. Shapira MY, Zeira E, Adler R, Shouval D. Rapid seroprotection against hepatitis B following the first dose of Pre-S1/Pre-S2/S vaccine. J Hepatol 2001; 34: 123-7.
22. Zucherman JN, Zucherman AJ, Symington I et al. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines. Hepatology 2001; 34: 798-802.
23. Lo CM, Lau GK, Chan SC, Fan ST, Wong J. Efficacy of a pre-S containing vaccine in patients receiving Lamivudine prophylaxis after liver transplantation for chronic hepatitis B. Am J Transpl 2007; 7: 434-9.
24. de Villa VH, Chen YS, Chen CL Hepatitis B core antibody-positive grafts: recipient's risk. Transplantation 2003; 75: S49-53.
25. Barcena Marugan R, Garcia-Hoz F, Vazquez Romero M et al. Prevention of de novo hepatitis B infection in liver allograft recipients with previous hepatitis B infection or hepatitis B vaccination. Am J Gastroenterol 2002; 97: 2398-401.
26. Bienzle U, Gunther M, Neuhaus R et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003; 38: 811-19.
27. Lin CC, Chen CL, Concejero A et al. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transpl 2007; 7: 195-200.
28. Soejima Y, Ikegami T, Taketomi A et al. Hepatitis B vaccination after living donor liver transplantation. Liver Int 2007; 27: 977-82.